Bottom line
What is BTSRX's expense ratio?
BTSRX's expense ratio is 2.27%, or about $227 a year on every $10,000 invested. That is more expensive than 98% of core / intermediate bond funds we track (median 0.71%). It has no front-end sales load. Its expense ratio includes a 0.5% 12b-1 marketing fee.
Updated Apr 21, 2026
BTSRX fee table
| Net expense ratio | 2.27% |
|---|---|
| Gross expense ratio | 4.95% |
| Management fee | 0.65% |
| 12b-1 (distribution) fee | 0.5% |
| Other expenses | 3.53% |
| Acquired fund fees | 0.27% |
| Fee waiver / reimbursement | -2.68% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
| Redemption fee | 0% |
Source: Fund prospectus fee table, filed Apr 21, 2026
What BTSRX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| BTSRX | $230 | $1,248 | $2,266 | $4,817 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 2.27% expense ratio costs roughly $112,700 in lost growth, versus about $40,300 for the median core / intermediate bond fund (0.71%).